Engaging men in HIV treatment and prevention

Lancet. 2018 Dec 1;392(10162):2334-2335. doi: 10.1016/S0140-6736(18)32994-5.

Authors

Adeola O Adeyeye¹, Michael J Stirratt², David N Burns³

Affiliations

¹ Division of AIDS/National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA. Electronic address: [email protected].
² Division of AIDS Research/National Institute of Mental Health, National Institutes of Health, Rockville, MD 20852, USA.
³ Division of AIDS/National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.

PMID: 30527600
DOI: 10.1016/S0140-6736(18)32994-5

No abstract available

MeSH terms

Africa South of the Sahara / epidemiology
Anti-Retroviral Agents / therapeutic use
Delivery of Health Care / standards*
Delivery of Health Care / trends
Female
HIV / drug effects
HIV Infections / diagnosis
HIV Infections / drug therapy*
HIV Infections / prevention & control*
Humans
Male
Mortality
Pre-Exposure Prophylaxis
Risk-Taking
Sexual Behavior / psychology*
Sexual Behavior / statistics & numerical data
United States / epidemiology

Substances

Anti-Retroviral Agents